Skip to content

Comparing Muscle Relaxant Rocuronium with and without Magnesium to evaluate the ideal intubating condition

A comparative study to evaluate the ideal intubating condition with non-depolarising muscle relaxant Rocuronium with and without pre-treatment with Magnesium Sulphate - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/058087
Enrollment
49
Registered
2023-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Rocuronium Bromide: Dose: 0.9 mg/kg, Frequency: Oncem Route of Administration: Intravenous (IV), Total Duration of Administration: Over 60 seconds. Control Intervention1: Rocuronium an

Sponsors

Medical College and Hospital, Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients scheduled for elective surgeries under general anaesthesia. Patients with physical status ASA I and ASA II Patients with malampati score I and II.

Exclusion criteria

Exclusion criteria: Patients refusal for being included in the study. Patients allergic to any study drug. Patients with physical status ASA more than II. Patients with difficult airway like malampati class >2, restricted neck movement or spinal deformity, mouth opening 5. Patients suffering from renal or cardiovascular issues. 6. Patients with history of malignant hyperthermia 7. Pregnancy

Design outcomes

Primary

MeasureTime frame
Cooper et al criteria, i.e. for jaw relaxation, vocal chord position, and response to intubationTimepoint: 30 sec, 45 sec, 60 sec, 75 sec, 90 sec

Secondary

MeasureTime frame
Ease of Intubation: Assess how easily the intubation is performed in each group. Hemodynamic Stability: Monitor and compare changes in blood pressure, heart rate, and oxygen saturation during intubation. Incidence of Complications: Record any complications during or after intubation.Timepoint: Pre-Induction: Assess baseline vital signs before interventions. Intubation: Collect data during and immediately after intubation. Post-Intubation: Monitor vital signs at specific intervals post-intubation.

Countries

India

Contacts

Public ContactDr Anisha Das

Medical College and Hospital

anjanagdastidar@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026